Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTP4A2P1 is a non-coding pseudogene related to the protein tyrosine phosphatase 4A2 gene (PTP4A2). It does not encode a functional protein and is not considered a direct therapeutic target. There is common confusion between PTP4A2P1 and its protein-coding counterpart PTP4A2, which encodes an enzyme involved in cell cycle progression, tumorigenesis, and regulation of intracellular signaling. Additionally, aliases like 'h-PRL-1' are often misattributed to PTP4A2, but more accurately refer to PTP4A1.
Not applicable (as a pseudogene, PTP4A2P1 does not have a protein-level mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PTP4A2 pseudogene 1 (PTP4A2P1).